Human Lymphocyte Antigens in Graves’ Disease: Correlation With Persistent Course of Disease

This publication has 25 references indexed in Scilit:

• Serum thyroglobulin concentration as an indicator for assessing thyroid stimulation in patients with graves' disease during antithyroid drug therapy
  The American Journal of Medicine, 1990
• Prospective multicentre study on the prediction of relapse after antithyroid drug treatment in patients with Graves' disease
  Acta Endocrinologica, 1989
• Retrospective revaluation of the significance of thyroid microsomal antibody in the treatment of Graves' disease
  Acta Endocrinologica, 1987
• THE ABILITY OF THE SERUM THYROTROPHIN RECEPTOR ANTIBODY (TRAb) INDEX AND HLA STATUS TO PREDICT LONG‐TERM REMISSION OF THYROTOXICOSIS FOLLOWING MEDICAL THERAPY FOR GRAVEs' DISEASE
  Clinical Endocrinology, 1986
• Serum Triiodothyronine to Thyroxine Ratio: A Newly Recognized Predictor of the Outcome of Hyperthyroidism due to Graves' Disease*
  Journal of Clinical Endocrinology & Metabolism, 1986
• Thyrotropin-Releasing Hormone Testing during Antithyroid Drug Treatment of Graves' Disease as an Indicator of Remission*
  Journal of Clinical Endocrinology & Metabolism, 1985
• Reappraisal of the 3,5,3′-Triiodothyronine-Suppression Test in the Prediction of Long Term Outcome of Antithyroid Drug Therapy in Patients with Hyperthyroid Graves’ Disease
  Journal of Clinical Endocrinology & Metabolism, 1984
• Comparison of Effects of High and Low Dosage Regimens of Antithyroid Drugs in the Management of Graves’ Hyperthyroidism*
  Journal of Clinical Endocrinology & Metabolism, 1983
• PREDICTION OF RELAPSE IN HYPERTHYROID GRAVES' DISEASE
  The Lancet, 1980
• RESPONSE TO TRIIODOTHYRONINE AS INDEX OF PERSISTENCE OF DISEASE IN THE THYROID REMNANT OF PATIENTS IN REMISSION FROM HYPERTHYROIDISM 1
  Journal of Clinical Investigation, 1956